Zeltiq Aesthetics Report issue

For profit Phase 4
Founded: Pleasanton CA United States (2005)
Status: Acquired by Allergan PLC (2015) (2017) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2018
NCT03510598
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Zeltiq Aesthetics